JanSport News Paul Delorey, a member of the "original" Expedition Inspiration Fund team, is retiring as President of JanSport in December of this year. Not only was Delorey on the Aconcagua summit team, he was instrumental in the financial success of the event, as JanSport was the underwriter of the climb in Argentina. Mt. Aconcagua, at 22,841' is the highest mountain in the western hemisphere. In 1995 Laura Evans and Peter Whittaker lead a team of 17 breast cancer survivors to face the second greatest challenge of their lives. This was made possible by the support of Paul Delorey and the entire JanSport team. JanSport has continued to support Expedition Inspiration in the years since. We wish Paul the best in his retirement-though we know Paul won't be idle! Thank you and good luck! Research Funding As a result of the 2001 Symposium and to encourage collaboration, the Expedition Inspiration Medical Board has awarded the following grants: A $15,000 Collaborative Grant has been made to Drs. Kathleen Grant, California Pacific Medical Center and Stefanie Jeffrey of Stanford University for their work on "Comparison of Molecular Markers (Steroid Receptors) in Asian and Caucasian Breast Cancer Patients." A $20,000 Outstanding Young Researcher Award has been make to Lisa Newman, MD for the Karmanos Cancer Institute for her work-"Feasibility of Evaluating Breast Cancer Patients with Nipple Aspirates and Ductal Lavage." Funds for these grants were raised at the 2000 Pinnacle Picnic held in Sun Valley, Idaho. Thank you to all who attended and donated to the picnic and auction. A complete list of grants is available on our website. The Fifth Annual Expedition Inspiration Medical Symposium "Hormones in the Etiology, Prognosis, Prevention and Treatment of Breast Cancer" held in March in Sun Valley, Idaho, brought together seventeen researchers from around the country. They spent two intensive days discussing this aspect of breast cancer. The format of the Symposium was an interactive workshop to encourage discussions of the general issues of breast cancer, with special emphasis on this year's subject. Several important conclusions were reached, resulting in a consensus statement which suggests promising avenues for future research. Highlights of this consensus statement, to be published in a forthcoming issue of "Breast Cancer Research and Treatment," include: Estrogen-receptor positive (ER+) breast cancers are more responsive to hormone therapy. There are at least two distinct forms of ER+ receptors; further work in characterizing these forms should result in more effective use of hormone therapy. Prevention of breast cancer by alteration of the timing of hormonal exposure during a woman's lifetime (beginning before birth), or by dietary means, is an area of great potential but in need of far more studies. Please see the complete summary statement on our website www.expeditioninspiration.org. Participants included: Samuel Hellman, MD, University of Chicago; Ronald V. Dorn, MD, Mountain States Tumor Institute; Marc Lippman, MD, University of Michigan; William Hryniuk, MD, Karmanos Cancer Institute; Gini F. Fleming, MD, University of Chicago Medical Center; Julie Gralow, MD, University of Washington Medical Center; Geoffrey Greene, MD, University of Chicago; Robert Hoover, MD, National Cancer Institute; Stefanie Jeffrey, MD, Stanford University; Malcolm Pike, PhD, USC Keck School of Medicine; Christopher Benz, MD, University of California, San Francisco; Malcolm Mitchell, MD, Karmanos Cancer Institute; Leena Hilakivi-Clark, Georgetown University Medical Center; Suzanne Conzen, MD, University of Chicago Medical Center; Craig Henderson, MD, ALZA; Kathleen Grant, MD, California Pacific Medical Center and John Lung, MD, Mountain States Tumor Institute.